OCAK, T. Et Al. 2024. Secukinumab May Be an Effective Treatment Option for Axial Spondyloarthritis and Psoriatic Arthritis Patients with a History of Malignancy: Multicenter Real-Life Experience from Turkey. JOURNAL OF CLINICAL MEDICINE , vol.13, no.20 .

OCAK, T., YAĞIZ, B., Ocak, B., Yogurtcu, O., BAŞIBÜYÜK, F., Tezcan, D., ... Ermurat, S.(2024). Secukinumab May Be an Effective Treatment Option for Axial Spondyloarthritis and Psoriatic Arthritis Patients with a History of Malignancy: Multicenter Real-Life Experience from Turkey. JOURNAL OF CLINICAL MEDICINE , vol.13, no.20.

OCAK, TUĞBA Et Al. "Secukinumab May Be an Effective Treatment Option for Axial Spondyloarthritis and Psoriatic Arthritis Patients with a History of Malignancy: Multicenter Real-Life Experience from Turkey," JOURNAL OF CLINICAL MEDICINE , vol.13, no.20, 2024

OCAK, TUĞBA Et Al. "Secukinumab May Be an Effective Treatment Option for Axial Spondyloarthritis and Psoriatic Arthritis Patients with a History of Malignancy: Multicenter Real-Life Experience from Turkey." JOURNAL OF CLINICAL MEDICINE , vol.13, no.20, 2024

OCAK, T. Et Al. (2024) . "Secukinumab May Be an Effective Treatment Option for Axial Spondyloarthritis and Psoriatic Arthritis Patients with a History of Malignancy: Multicenter Real-Life Experience from Turkey." JOURNAL OF CLINICAL MEDICINE , vol.13, no.20.

@article{article, author={TUĞBA OCAK Et Al. }, title={Secukinumab May Be an Effective Treatment Option for Axial Spondyloarthritis and Psoriatic Arthritis Patients with a History of Malignancy: Multicenter Real-Life Experience from Turkey}, journal={JOURNAL OF CLINICAL MEDICINE}, year=2024}